Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN).
Virginie BundLise LecointreMichel VeltenLobna OuldamerSofiane BendifallahMartin KoskasPierre-Adrien BolzePierre CollinetGeoffroy CanlorbeCyril TouboulCyrille HuchonCharles CoutantEmilie FallerThomas BoisraméJustine GantzerMartin DemarchiJean-Jacques BaldaufMarcos BallesterVincent LavouéChérif AkladiosPublished in: Journal of clinical medicine (2020)
patients who had received SL (Group 2) had significantly higher PFS regardless of node-positivity status when compared to those who had not received SL (Group 1).